The metabolism of cholesterol and its 5-dihydro derivative, cholestanol, was investigated by means of sterol balance and isotope kinetic techniques in 3 subjects with cerebrotendinous xanthomatosis (CTX) and 11 other individuals. All subjects were hospitalized on a metabolic ward and were fed diets practically free of cholesterol and cholestanol. After the intravenous administration of [1,2-3 H]cholestanol, the radioactive sterol was transported and esterified in plasma lipoproteins in an identical manner to cholesterol. In these short-term experiments, the specific activity-time curves of plasma cholestanol conformed to two-pool models in both the CTX and control groups. However, cholestanol plasma concentrations, total body miscible pools, and daily synthesis rates were two to five times greater in the CTX than control individuals. The short-term specific activity decay curves of plasma [4-14 C]cholesterol also conformed to two-pool models in both groups. However, in the CTX subjects the decay was more rapid, and daily cholesterol synthesis was nearly double that of the control subjects. Plasma concentrations and the sizes of the rapidly turning over pool of exchangeable cholesterol were apparently small in the CTX subjects, and these measurements did not correlate with the large cholesterol deposits found in tendon and tuberous xanthomas.
A B S T R A C T The metabolism of cholesterol and its 5-dihydro derivative, cholestanol, was investigated by means of sterol balance and isotope kinetic techniques in 3 subjects with cerebrotendinous xanthomatosis (CTX) and 11 other individuals. All subjects were hospitalized on a metabolic ward and were fed diets practically free of cholesterol and cholestanol. After the intravenous administration of [1,2-3H] cholestanol, the radioactive sterol was transported and esterified in plasma lipoproteins in an identical manner to cholesterol. In these short-term experiments, the specific activity-time curves of plasma cholestanol conformed to two-pool models in both the CTX and control groups. However, cholestanol plasma concentrations, total body miscible pools, and daily synthesis rates were two to five times greater in the CTX than control individuals. The short-term specific activity decay curves of plasma [4Y'tC]cholesterol also conformed to two-pool models in both groups. However, in the CTX subjects the decay was more rapid, and daily cholesterol synthesis was nearly double that of the control subjects. Plasma concentrations and the sizes of the rapidly turning over pool of exchangeable cholesterol were apparently small in the CTX subjects, and these measurements did not correlate with the large cholesterol deposits found in tendon and tuberous xanthomas.
Despite active cholesterol synthesis, bile acid formation was subnormal in the CTX subjects. However, bile acid sequestration was accompanied by a rise in plasma cholestanol levels and greatly augmented fecal cholesDr. Salen is a recipient of a Clinical Investigatorship
INTRODUCTION
The occurrence of tendon xanthomatosis has long been recognized as a manifestation of severe hypercholesterolemia (Type II, hyperbetalipoproteinemia) and usually signifies that plasma concentrations are in excess of 300 mg/100 ml (1) (2) (3) . However, in the rare inherited disease, cerebrotendinous xanthomatosis (CTX),' histologically similar xanthomas develop, but plasma cholesterol concentrations are remarkably low (4, 5) . Other features that distinguish CTX from primary hyperbetalipoproteinemia include progressive neurologic dysfunction, cataracts, mild pulmonary insufficiency, and the development of xanthomatous lesions in the brain and lung; coronary atherosclerosis is common to both conditions (6) . In 1968 Menkes, Schimschock, and Swanson (7) noted that brain tissue in CTX contained ex- IHD, hypercholesterolemia (Type II) * According to life insurance tables of weight for height, age, and sex (9) .
Sisters, D. family (6) . § IHD, ischemic heart disease. ¶ Hyperlipoproteinemia was diagnosed by paper-strip electrophoresis according to Fredrickson, Levy, and Lees (3) . traordinary amounts of cholestanol,' the 5a-dihydro derivative of cholesterol.
In subsequent studies, we have confirmed the high content of cholestanol in CTX brain but have detected also 10-100 times more cholestanol in 12 other tissues from a CTX subject (6) . Although trace amounts of this sterol are found in practically all mammalian tissues (8) , the demonstration of such large amounts of cholestanol throughout the body in CTX suggests a role for this sterol in the pathogenesis of the disease. Furthermore, tissue cholesterol levels were 30% higher than normal, which indicated an associated defect in cholesterol metabolism (6) .
In the present study, cholesterol and cholestanol metabolisms were examined simultaneously in three CTX subjects by sterol balance and isotope kinetic methods.
Similar studies were performed in 11 other individuals for comparison. Our results in the subjects with CTX showed that the synthesis rates for cholesterol and cholestanol were augmented and suggested that overproduction of these sterols was responsible for the de- velopment of elevated tissue concentrations. 2 The following systematic names are given to sterols referred to by trivial names: cholestanol, 5a-cholestan-3,3-ol; cholesterol, cholest-5-en-3,8-ol; A7-cholestenol, 5a-cholest-7-en-3,8-ol; dihydrolanosterol, lanosta-8-en-3p-ol.; lanpsterol, lanosta-8,24-dien-3g-ol.
METHODS

Clinical aspects
Studies were carried out on the metabolic ward at the Rockefeller University Hospital and at the Manhattan Veterans Administration Hospital. The age, sex, and body build, plasma lipid levels, and clinical diagnosis of each patient are given in Table I . The three patients with CTX were from two families. Patients 1 and 3 were sisters, and both exhibited moderate neurological impairment, Achilles tendon xanthomas, and low plasma cholesterol concentrations. Patient 2 manifested no evidence of neurologic dysfunction but had large Achilles tendon xanthomas, mild pulmonary insufficiency, and a low plasma cholesterol concentration. Complete clinical descriptions have been published elsewhere (6, 10, 11) . 11 additional patients were studied for comparison and exhibited a mixed group of lipid abnormalities including two cases of xanthomatosis.
Diets
Food intakes in patients 1 through 8, 13, and 14 consisted exclusively of orally administered liquid formula feedings in which protein contributed 15%7, fat 40%, and glucose 45% of the total caloric intake; vitamins and mineral supplements were given as described previously (12) . The fat content of each formula is listed in Table II and consisted exclusively of cottonseed oil in patients 14 and corn oil in patients 13 and 14. These fats do not contain cholesterol, but cottonseed oil contains approximately 3.2 mg 8-sitosterol/g and corn oil contains 1.9 mg 8-sitosterol/g. Samples of each formula diet were analyzed repeatedly for sterol content as tests of formula homoAbnormal Steroid Synthesis in Cerebrotendinous Xanthomatosis Formula-corn oil --14
Formula-corn oil --geneity. They contained only small amounts of cholesterol and no cholestanol. Based upon these analyses, the subjects ingested less than 45 mg/day of cholesterol. Patients 9-12 ate low-cholesterol unsaturated fat diets that consisted of balanced meals selected by the individual but devoid of foods containing large amounts of cholesterol. A daily food record kept by each patient was reviewed by a dietitian, and the daily cholesterol intake was estimated at between 100 and 250 mg/day. Analysis of samples of food revealed that cholestanol constitutes 0.1-0.2% the amount of cholesterol.
The caloric intake was adjusted in each patient to maintain total body weight at a constant level throughout each study. Each individual in whom balance studies were performed received 300 mg/day of chromic oxide as an internal standard to monitor fecal flow (13) .
Radioactive compounds and isotope counting [1,2- [1,2-3H] cholestanol. In all cases, the radiosterols were dissolved in 1 ml of ethanol that was then dispersed in 150 ml of physiologic saline; the entire dispersion was immediately infused by vein.
Radioactivity was assayed in a Packard Tri-Carb Scintillation Counter Model 3003 (Packard Instrument Co., Inc., Downers Grove, Ill.). The purified sterols were dissolved in toluene phosphor (4.2% Liquiflor, New England Nuclear). Appropriate corrections were made for quenching, crossover, and background as described by Miettinen, Ahrens, and Grundy (14) .
Steroid analyses
Complete stool collections were obtained throughout each study for patients [1] [2] [3] [4] [5] [6] [7] [8] 13 , and 14 and were combined into 4-day pools. Fecal neutral and acidic steroids were isolated separately, and their masses and specific activities were measured by methods previously developed (14, 15) . These TLC and GLC procedures permit the essential distinction to be made between plant sterols and cholesterol and between the two families of bacterial conversion products derived from plant sterols and cholesterol during intestinal transit (5p, 3,3-OH, and 5p, 3-keto compounds).
Corrections for unexplained losses of cholesterol (12%, in the CTX subjects and 18% in the controls) during intestinal transit were based upon the recovery of nonlabeled (3-sitosterol inherent in the formula diets (16) . Variations in fecal flow and excretion of bile acids were corrected by the recovery of chromic oxide (13) .
In order to measure the concentration of cholestanol in plasma or feces, it was necessary to modify the analysis procedure for fecal sterols. A Plasma cholesterol and triglyceride concentrations were measured biweekly using a semiautomated method (17, 18) ; on a sample of the same extract used in these determinations '4C radioactivity was assayed, and the specific activity of cholesterol (dpm/mg) was expressed in a semilogarithmic plot.
Free and esterified sterols in plasma
The lipids in 2 ml of plasma were extracted in 38 ml of chloroform: methanol, 2: 1 after each subject had received [4-1'C]cholesterol and [1,2-3H] cholestanol intravenously.
The solvent was evaporated, and the lipid residue was applied on 0.5-mm thick silica gel H plates; these were developed in petroleum ether: ethyl ether: acetic acid, 85: 15: 0.5. The sterol bands were detected under ultraviolet illumination after being sprayed with a half-saturated aqueous solution of Rhodamine 6G. In this system the free sterols had an R, value of 0.30 and esterified sterols 0.90. The bands corresponding to free and esterified cholesterol were collected separately, and measurements of sterol esterification were made by determining the proportion of both isotopes in the free and ester fractions.
Lipoprotein isolation
Lipoproteins were isolated from 12 ml of plasma in the Beckman model L2-65B ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) according to the method of Havel, Eder, and Bragdon (19) . For separation of low and very low-density lipoproteins (LDL and VLDL), ultracentrifugation was carried out at about 100,000 g at 15'C for 16 h in a Type 50 titanium rotor; for the separation of high-density lipoproteins (HDL), ultracentrifugation was carried out for 40 h.
Experimental design CHOLESTANOL TURNOVER
In patients 1, 2, 4, and 9-12, the turnover of cholestanol was determined in the plasma from specific activity-time curves after intravenous labeling with [1-2-H]cholestanol.
Assuming a two-pool model (20) 
RESULTS
Plasma cholesterol and cholestanol concentrations.
Measurements of plasma neutral sterols from three CTX and five control subjects on formula diets containing 40% cottonseed oil are presented in Table IIIA . Despite the presence of tendon xanthomas, exceedingly low plasma cholesterol levels were found in the CTX subjects (95 mg/100 ml vs. 311 mg/100 ml). However, plasma cholestanol concentrations in the CTX subjects were almost twice those of controls (1.2 mg/ 100 vs. 0.74 mg/100 ml). Therefore, there was six times more cholestanol relative to cholesterol in the CTX plasma than in the controls.
When the CTX subjects ate regular solid-food diets, the plasma concentrations of both cholesterol and cholestanol increased 25% (Table IIIB) . It is not clear whether the rise in plasma neutral sterols was related to the cholesterol and cholestanol content of regular food, to the effect of saturated fats present in solid food, or to some other unidentified factor.
Plasma lipoprotein, transport of cholestanol. In order to determine in which lipoprotein fraction cholestanol is transported, plasma specimens from two CTX individuals were fractioned into the three major lipoprotein groups (VLDL, LDL, and HDL) by preparative ultraAbnormal Steroid Synthesis in Cerebrotendinous Xanthomatosis Percentage cholestanol per total sterols.
centrifugation. The absolute quantity of cholesterol and cholestanol was determined by GLC in each lipoprotein fraction and is reported in Table IV . Cholestanol accompanied cholesterol in all three fractions, with the highest amount in the LDL fraction. The ratio of cholesterol to cholestanol was reasonably constant throughout all three lipoprotein fractions in patient 3 but was higher in the VLDL and HDL fraction of patient 1: evidently a plasma lipoprotein that serves specifically for cholestanol transport was not detected by these methods.
The esterification of cholesterol and cholestanol. The rates of esterification of both sterols were studied in patients 1 and 2 with CTX and in patient 4, who was normolipidemic. These subjects were given [4- Goodman and Noble (22) . The specific activities of cholestanol isolated from the feces of this subject also are plotted (open circles) in this figure. They correspond closely with the specific activities of plasma cholestanol, indicating that unlabeled cholestanol was not formed by intestinal bacteria in the colon.
Estimation of cholestanol turnover by the sterol balance method and isotope kinetic method. In two subjects with CTX (patients 1 and 2) and one normolipidemic subject (patient 4) cholestanol turnover was calculated by the isotopic balance technique after [1,2-5H]-cholestanol was administered intravenously. The calculation should be valid because the specific activities of fecal cholestanol and presumably of bile acids derived from cholestanol are the same as the specific activity of plasma cholestanol (Fig. 2) outputs of cholestanol ranged from 22 to 38 mg/day in the CTX subjects and from 7 to 13 mg/day in the control subjects. The output of acidic steroids derived from cholestanol ranged from 6 to 9 mg/day in the CTX subjects and from 2 to 5 mg/day in the control subjects. Since these individuals had attained the metabolic steady state as manifested by constant body weight and plasma cholestanol concentrations, the sum of the fecal excretion of cholestanol and allo bile acids derived from cholestanol reflects daily turnover.
In two CTX subjects (patients 1 and 2) and five other subjects (patients 4, and 9-12) cholestanol turnover also was estimated through the calculation of production rates (PRA) by mathematical analysis of the specific activity decay curves, since these curves conformed to two-pool models. The 14 21 eters that underlie these calculations are presented in Table VI , and the production rates are included in Table VB . Cholestanol turnover (PRA) ranged from 6.0 to 18.6 mg/day in the control subjects (mean 11.8 +6.0) and were 48 and 57 mg/day (average 52.5) in the two CTX subjects. The difference between the sterol balance method and compartmental analysis of the two-pool model was 16% and is sufficiently close to support the validity of the turnover values derived by these techniques. Average cholestanol PRA'S were 3-4 times greater in the CTX subjects than the controls.
Estimates of cholestanol synthesis. Since cholestanol was not present in the formula diets of patients 1 through 4 or was found in only trace quantities in the regular food diets (patients 9-12), it becomes clear that in the metabolic steady state, daily turnover equals the amount of cholestanol synthesized each day. Therefore, since the control group included both normolipidemic and hyperlipidemic individuals, high cholestanol synthesis is present in CTX.
Calculation of the size of the two miscible pools of cholestanol. From the mathematical analysis of the plasma cholestanol specific activity decay curves, an estimate of the sizes of the rapidly turning-over pool (MA) and the minimum size of the slowly turning-over pool (MB) of cholestanol can be obtained and are presented in Table VI . MA in the two CTX subjects (patients 1 and 2) was 212 mg and 148 mg, respectively; both values exceeded the mean value for pool A (MA = 48+23 mg) in the control subjects by 4 and 3 times, respectively. MB (minimum) for the two CTX subjects was 212 mg and 67 mg, and these values were 3 and 1.5 times higher than the mean value for MB (43+26 mg) calculated in the five control patients. It Estimation of cholesterol turnover by two independent methods. In two patients with CTX (patients 1 and 2) and five control subjects (patients 4 through 8) cholesterol turnover was determined by analysis of plasma specific activity-time curves after intravenous labeling with [4-"C]cholesterol. Cholesterol specific activities were measured for 5-10 wk (Table II) and in all cases conformed to two-pool models (22) . The curves for the two CTX subjects and one normolipidemic subject are shown in Fig. 3 (Table VIIIA) were 1085 mg/day and 987 mg/day, respectively, whereas the mean value in the control subjects was 736 mg/day. Since the CTX subjects were small, the differences were even larger when the turnover rates were expressed as milligram per kilogram per day: the average value for the two CTX subjects was 18.2 mg/kg/day as compared with a mean value of 11.1±3.6 mg/kg/day in the controls.
Since diets were low in cholesterol, turnover is equivalent to endogenous synthesis.
Cholesterol turnover was measured simultaneouslv by the sterol balance method. The results are presented in Table VIIIB . For the control subjects, the correspondence of turnover rates between the sterol balance and isotope kinetic methods was quite good; 674± 187 mg/day vs. 736±261. However, in the two CTX subjects it was not possible to measure accurately the output of endogenous neutral sterols by the chromato- Table VIII . As was the case for compartmental analyses of the two-pool model, the total excretion of steroids derived from cholesterol was quite high in patient 1 but did not differ from the control values for patient 2. However, when total steroid outputs were expressed again as mg/kg/day to compensate for variation in body weight, cholesterol turnover was 39% higher in patient 1 and 22% higher in patient 2 than the mean value in the control subjects. In interpreting these results it is important to stress that the control patients were a heterogeneous group not only in terms of their plasma lipoprotein abnormalities but also in body build. Patient 8 was obviously obese (18% over ideal weight), and we believe her augmented cholesterol synthesis was related to her excess body weight (23) . Furthermore, although cholesterol synthesis was high in the CTX subjects, it would not be surprising to find similar rates in individuals with other lipid disorders.
The average difference between the sterol balance and isotope kinetic methods in the two CTX subjects was 22%, while in all seven patients it was 13.5%. These data thus show the expected variation found in two previous studies where the mean difference between the methods in ten subjects was 15% (24) , and in four subjects was 8% (25) . The comparability of turnover values by these two independent techniques supports the premises on which the methods are based and adds confidence in the validity of the turnover results.
Despite the high flow of total fecal steroids, bile acid outputs were remarkably small in the CTX subjects (Table VIII) . (26, 27) and also because of the possibility that some cholesterol was synthesized or degraded in the tissues of this pool. Despite these qualifications, it is still surprising that both body miscible pools (MA + MB minimum) of cholesterol were small in the CTX subjects, especially in view of the large tendon xanthomata and tissue sterol deposits that characterize these individuals (6) .
Effects of cholestyrainine. The effects of interrupting the enterohepatic circulation of bile acids on plasma cholestanol concentrations and the fecal excretion of cholestanol are presented in Fig. 4 . During treatment with 10 g of cholestyramine/day, fecal cholestanol output rose from an average of 22 to 46 mg/day and allo bile acid' excretion increased from an average of 9 to 22 mg/day. Plasma cholestanol levels also increased from a mean of 1.4 mg/100 ml to almost 4 mg/100 ml.
Effect of clofibrate on sterol metabolism in Patients with CTX. After a control period, patients 1 and 2 were given 2 g of clofibrate each day for 29 and 21 days, respectively. In the control period both patients had received [4- ments of cholesterol and cholestanol balance were made by the isotopic balance technique. The effects of clofibrate on the specific activity decay curves of plasma cholesterol are illustrated in Fig. 5 . In the control period, the decay in plasma specific activity was rapid in both patients. However, when clofibrate was introduced, there was an abrupt decrease in the rate of decay. A similar change has been noted previously in many patients with various types of hyperlipemia (28) . The effects of clofibrate on plasma sterol concentrations and sterol balance are illustrated in Fig. 6 . During this treatment, plasma cholesterol concentrations did not change significantly. Similarly little effect was noted on total sterol balance, although bile acid outputs increased in both subjects.
In contrast, much greater effects were observed on cholestanol metabolism during clofibrate treatment; plasma cholestanol concentrations were reduced 56% in patient 1 Cholestanol metabolism Turnover of cholestanol. According to the theory of the two-pool model, the daily cholestanol PRA should equal the amount of new cholestanol that enters the more rapidly exchangeable pool (MA) exclusive of recirculated cholestanol (22) . Analysis of the decay curve of plasma specific activity after pulse labeling indicated that the turnover of cholestanol conformed to a twopool model (Fig. 1) . Mathematical analysis of the specific activity decay curves provided estimates of the daily PRA. In seven studies turnover calculated in this manner was approximately fourfold greater in two CTX subjects than in control subjects. Values pendent methods for the turnover of the plant sterol f3-sitosterol in man (25) . It is of interest that although this sterol enters the body by a different route [9-sito- sterol is absorbed from the diet, while cholestanol is produced within the body (see below)], the plasma specific activity decay curves of both sterols conform to a two-pool model. Perhaps a similarity of lipoprotein transport (Table IV) accounts for the comparability.
Evidence for endogenous cholestanol synthesis. Two additional lines of evidence were presented in this paper showing that cholestanol was formed endogenously in both CTX and control subjects. (a) In all four patients who were fed cholestanol-free diets (patients 1-4) constant plasma levels were attained (Table   III) . Since the diets were free of cholestanol new synthesis served as the major source of plasma cholestanol. (b) After [3H]cholestanol was given intravenously, the specific activity of plasma cholestanol equaled the specific activity of fecal cholestanol (Fig. 2) . This observation ruled out the possibility that cholestanol arose through the reduction of cholesterol by intestinal bacteria. If this path had been followed, the specific activity of fecal cholestanol would have been lower than plasma due to a dilution of fecal cholestanol by that produced from bacteria. These observations supplement our previous study concerning the biosynthetic pathway for cholestanol. Although the precise pathway was not completely elucidated, cholestanol was shown to have originated! endogenously from cholesterol (29) . Two experiments were presented: (a) the direct transformation of [4-14C] (27) . In 12 of the 17 patients a third exponential appeared after 25 wk, and probably reflected a third kinetic pool of more slowly exchangeable cholesterol. Samuel, Perl, Holtzman, Rochman, and Lieberman in another study also noted that if xanthomata were present, the specific activity of xanthoma cholesterol differed widely from plasma cholesterol specific activity and indicated that this cholesterol might constitute a fourth more slowly exchangeable kinetic pool (32) and might be a problem in patients with xanthomatosis. When the various kinetic parameters were derived by input-output analysis and compared with similar values obtained from analysis of 10-12-wk segments of the same curves, important quantitative differences between the short-term and long-term kinetic values were noted. The cholesterol PRA derived from the 50-wk curves were 8-14% lower than for the 10-12-wk curve. MA did not differ between the methods, but MB minimum was almost 40% higher when derived from the long-term decay curves. A similar criticism of the two-pool model for calculating cholesterol turnover has been presented by Goodman, Noble, and Dell, who analyzed cholesterol-specific radioactivity-time curves in six subjects for 32-41 wk (26) . Although visual analysis of all curves suggest a two-pool model, computer analysis revealed the long-term curves best fit a three-pool model. Calculation of cholesterol PRA were 8-9% lower when derived from the three-pool model. Pool A was essentially unchanged, but minimum or maximum values for MB differed appreciably between the two kinetic methods. Therefore, if PRA was reduced 8-14% in our seven subjects (Patients 1, 2, and 4-8), much closed correspondence with the turnover values derived by the sterol balance method would be observed. Finallv, it should be noted that another potential source of error concerns the loss of cholesterol from the skin. Bhattacharyya, Conner, and Spector reported that between 10 to 15% of the daily turnover of cholesterol was lost through the skin (33) . Therefore, the fecal outputs of cholesterol and bile acid would have to be corrected upward by the loss of cholesterol through the epidermis. Despite these qualifications, average cholesterol synthesis (mg/kg/day) in the CTX subjects was 39% higher if determined by the isotope kinetic method and 32% higher if determined by the sterol balance method than in the control patients. These quantitative measurements are supported by two additional observations. First, substantial quantities of lanosterol, dihydrolanosterol, and A7-cholestenol have been detected in the bile of these subjects (6) . These sterols are intermediates in cholesterol biosynthesis, and we suspect their secretion in the bile signifies active hepatic cholesterol synthesis. Second, the hepatic level of phydroxy, P-methylglutaryl CoA reductase, the rate-determining enzyme of cholesterol biosynthesis, was 3-4 times greater in patient 2 (CTX) than 16 other individuals who were either normal or manifested lipid abnormalities.4 This hepatic microsomal enzyme controls the rate of formation of mevalonic acid from 9-hydroxy, 8-methylglutaryl CoA, which is the first totally committed step in the cholesterol biosynthetic pathway. The combination of these independent lines of evidence leads us to conclude that cholesterol synthesis is elevated in CTX.
Bile acid turnover. In order to maintain a constant enterohepatic pool of bile acids, new production must equal the fecal loss of bile acids. Determination of fecal acidic steroid excretion must then equal hepatic bile acid synthesis. In the CTX subjects, the average daily excretion of fecal acidic steroids was 46% less than in the controls (Table VIII) . This suggested that bile acid formation was extremely low in this disease.
'Nicolau, G., S. Shefer, G. Salen, and E. H. Mosbach. 1973. Determination of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase activity in man. Submitted for publication.
Abnormal Steroid Synthesis in Cerebrotendinous Xanthomatosis
Previously, we reported that biliary bile acid composition was qualitatively abnormal in the CTX subjects and was characterized by an extremely low proportion of chenodeoxycholic acid (6) . The low fecal bile acid excretion probably eliminated the possibility that selective intestinal malabsorption of chenodeoxycholic acid was responsible for the deficiency of this bile acid in the bile. Recently, Garbutt and Kenny reported that the administration of cholestyramine to normal individuals reduced the proportion of chenodeoxycholic acid and concomitantly increased cholic acid in the bile (34) . However, this study did not distinguish the mechanism: either preferential intestinal loss of chenodeoxycholic acid or enhanced hepatic cholic acid synthesis could have occurred. However, in the CTX subjects cholestyramine should aggravate the deficiency of chenodeoxycholic acid in the bile. It is, therefore, noteworthy that cholestanol plasma levels and fecal outputs rose during this therapy.
Although clofibrate apparently interferes with cholestanol synthesis, the replacement of chenodeoxycholic acid in the gut seems a more logical therapy. As shown in a preliminary communication, the administration of 750 mg/day of this primary bile acid apparently resulted in a marked reduction in the synthesis of both cholesterol and cholestanol (35) . Although noticeable improvement in the clinical syndrome may require prolonged treatment, the apparent normalization of neutral sterol production with chenodeoxycholic acid is encouraging.
To summarize, the findings of this report suggest the overactive cholesterol and cholestanol synthesis were associated with impaired bile acid production in the CTX individuals. It is tempting to speculate that hyperactive neutral sterol synthesis occurred in response to a deficiency of bile acids in the enterohepatic circulation.
